These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15084687)

  • 21. Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures.
    Emm T; Metcalf JE; Lesko LJ; Chai MF
    Ann Allergy; 1991 Feb; 66(2):185-9. PubMed ID: 1899784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of nebulizer performance under various humidity conditions.
    Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
    J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form.
    Britland S; Finter W; Chrystyn H; Eagland D; Abdelrahim ME
    Biotechnol Prog; 2012; 28(5):1152-9. PubMed ID: 22887984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit.
    Turpeinen M; Nikander K
    Respir Care; 2001 Jan; 46(1):43-8. PubMed ID: 11175237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalation solutions--which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers--update 2013.
    Kamin W; Erdnüss F; Krämer I
    J Cyst Fibros; 2014 May; 13(3):243-50. PubMed ID: 24172851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical-chemical compatibility of cromolyn sodium nebulizer solution--bronchodilator inhalant solution admixtures.
    Lesko LJ; Miller AK
    Ann Allergy; 1984 Sep; 53(3):236-8. PubMed ID: 6433752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma.
    Shrewsbury SB; Bosco AP; Uster PS
    Int J Pharm; 2009 Jan; 365(1-2):12-7. PubMed ID: 18786624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmolality and pH of anti-asthmatic drug solutions.
    Desager KN; Van Bever HP; Stevens WJ
    Agents Actions; 1990 Nov; 31(3-4):225-8. PubMed ID: 2150739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosol Characteristics and Physico-Chemical Compatibility of Combivent
    Zhang R; Hu J; Deng L; Li S; Chen X; Liu F; Wang S; Mohammed Abdul KS; Beng H; Tan W
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial.
    Silverman M; Sheffer AL; Díaz PV; Lindberg B
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():14-20. PubMed ID: 16573704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
    Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of nebulized budesonide in severe exacerbation of bronchial asthma].
    Sereda VP; Svistov AS
    Klin Med (Mosk); 2004; 82(6):61-6. PubMed ID: 15344695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of previously uncontrolled adult asthma with budesonide inhalation suspension: five-year case histories.
    Gawchik SM
    Ann Pharmacother; 2007 Oct; 41(10):1728-33. PubMed ID: 17698895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The compatibility between packing material and ipratropium bromide aerosol].
    Yue ZH; Shen DD; Hu CQ
    Yao Xue Xue Bao; 2010 Aug; 45(8):1035-8. PubMed ID: 21351591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide.
    Gupta M; Bhargava HN
    J Pharm Biomed Anal; 2006 Feb; 40(2):423-8. PubMed ID: 16143482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.